Skip to content

LONA LONA Additional Paid-In Capital

Additional Paid-In Capital at other companies

Eli Lilly logo
Eli LillyLLY
$6.92B+0.2%
Arvinas logo
ArvinasARVN
$2.15B+2.0%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$1.13B+33.4%
Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
$621.56M+17.4%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$258.59M+6.0%
Erasca, Inc. logo
Erasca, Inc.ERAS
$1.47B+22.7%

Other financials

Income statement

See full
Operating income-$17.2M-80.5%
Net income-$32.9M-260%
EPS (diluted)-$1.73+26.1%

Balance sheet

See full
Cash & equivalents$32.8M+24.3%
Total debt$691.0K-38.2%
Total equity$49.3M+32.1%
Total assets$71.6M+64.5%

Cash flow

See full
Operating cash flow-$20.9M-42.5%
CapEx$28.0K-15.2%
Free cash flow-$26.0M+1.1%

Valuation

See full
Market cap$86.33M+223%
Enterprise value$54.18M

Returns & leverage

See full
Return on equity-298.8%-726pp
Debt / equity0.0×
Current ratio10.4×+3.1×

Where this comes from

Reported directly by LONA in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: LONA’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LONA's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LONA's additional paid-in capital?
LONA (LONA) reported additional paid-in capital of $594.02M in Q1 2026.
How has LONA's additional paid-in capital changed year-over-year?
LONA's additional paid-in capital increased by 31.2% year-over-year, from $452.62M to $594.02M.
What is the long-term trend for LONA's additional paid-in capital?
Over 5 years (2020 to 2025), LONA's additional paid-in capital has grown at a 11.3% compound annual growth rate (CAGR), from $315.29M to $539.55M.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.